Ketih McCrae
Director, Classical Hematology, Cleveland Clinic Taussig Cancer Institute · Case Western Reserve University
Credentials: · · · · ·
History
- Present
Classical Hematology · Case Western Reserve University
1982–1985
1978–1982
1974–1978
Research
Endothelial cells in physiology and in the pathophysiology of vascular disorders
Review · Blood · 1998 · 1,782 citations
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Blood Advances · 2019 · 1,051 citations
Dose of prophylactic platelet transfusions and prevention of hemorrhage
New England Journal of Medicine · 2010 · 504 citations
33 papers
- SC
30 papers · 15 as a resident
20 papers
13 papers
12 papers
9 papers
- MS
9 papers
9 papers
Grants
- 2023–2027
Mechanisms of Cancer Immunotherapy-Associated Thrombosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.9M · Cleveland Clinic Lerner Com-Cwru
- 2020–2026
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
National Heart, Lung, and Blood Institute · UH3
Contact PI · $3.8M · Cleveland Clinic Lerner Com-Cwru
- 2018–2025
Novel Approaches to Improve Prediction of Cancer-Associated Thrombosis
National Heart, Lung, and Blood Institute · U01
Contact PI · $4.7M · Cleveland Clinic Lerner Com-Cwru
- 2019–2020
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
National Heart, Lung, and Blood Institute · UG3
Contact PI · $876.1K · Cleveland Clinic Lerner Com-Cwru
Clinical trials
- 2019–2023
Pomalidomide for the Treatment of Bleeding in HHT
Principal investigator · Completed · Phase 2
The Cleveland Clinic
- 2015–2019
Principal investigator · Completed · Phase 1
The Cleveland Clinic
- 2010
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Principal investigator · Completed
Carelon Research
- 2009–2010
Principal investigator · Terminated · Phase 3
Carelon Research